SAMIL PHARMACEUTICAL CO.,LTD Logo

SAMIL PHARMACEUTICAL CO.,LTD

Researches and manufactures pharmaceuticals with a focus on ophthalmology and CDMO services.

000520 | KO

Overview

Corporate Details

ISIN(s):
KR7000520007
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 155 (방배동, 삼일제약 사옥), 서초구

Description

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-31 00:00
최대주주등소유주식변동신고서
Korean 43.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-15 00:00
최대주주등소유주식변동신고서
Korean 43.5 KB
2025-05-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-16 00:00
유상증자또는주식관련사채등의발행결과(자율공시)
Korean 5.6 KB
2025-04-16 00:00
자기주식처분결과보고서
Korean 21.3 KB
2025-04-11 00:00
주요사항보고서(자기전환사채만기전취득결정)
Korean 20.8 KB
2025-04-11 00:00
주요사항보고서(교환사채권발행결정)
Korean 32.5 KB
2025-04-11 00:00
기타경영사항(자율공시)
Korean 6.4 KB
2025-04-11 00:00
주요사항보고서(자기주식처분결정)
Korean 31.8 KB
2025-04-10 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-04-08 00:00
최대주주등소유주식변동신고서
Korean 41.8 KB
2025-04-04 00:00
최대주주등소유주식변동신고서
Korean 41.8 KB
2025-03-28 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.2 MB

Automate Your Workflow. Get a real-time feed of all SAMIL PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMIL PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMIL PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.